Followers
0
Following
0
Blog Posts
0
Threads
1,835
Blogs
Threads
Portfolio
Follower
Following
2021-10-18 16:53 | Report Abuse
Supermax rebound today closing green
Tomorrow public holiday
2021-10-15 21:34 | Report Abuse
Short selling not active nowadays to push down share price below RM2 just short term retailers and local institutions net selling nowadays
2021-10-15 14:50 | Report Abuse
Supermax strong buy queue 1 millions+ 2.16,2.15,2.14 not easy to push down share price now
2021-10-15 12:11 | Report Abuse
All glove stocks down today and share price downtrend still continues
2021-10-15 10:29 | Report Abuse
Short selling very low around 500k every day less than 1% total daily shares volumes
2021-10-15 09:27 | Report Abuse
Last year final dividend declared end October and payment 2 months later early January
2021-10-14 12:07 | Report Abuse
Kossan and Hartalega QR release coming less than 2 weeks.Supermax today strong support 2.15 more than 1.6 million buy queue
2021-10-14 09:20 | Report Abuse
Total short selling drops to 66 millions as of yesterday
2021-10-13 17:29 | Report Abuse
Waiting for Supermax share price stabilize as everyone waiting for Hartalega and Kossan QR another 2 weeks
2021-10-13 14:57 | Report Abuse
Strong support 2.15 with more than 1 millions shares queue buy
2021-10-13 13:59 | Report Abuse
Kossan and Hartalega QR release next 1-2 weeks but Supermax most probably end of next month
2021-10-13 11:36 | Report Abuse
Lowest price should be be pre pandemic price in 2019 around 80-90 sen
2021-10-13 11:14 | Report Abuse
Net short selling yesterday only 556k but price drop 10 sen with high volume 24 millions shares and total short selling already drops to 67 millions from 80 millions
2021-10-12 10:13 | Report Abuse
Director keeps disposing Supermax shares not a good signal
2021-10-12 09:53 | Report Abuse
Careplus next strong support RM1 as heavy selling continues
2021-10-12 09:50 | Report Abuse
Downtrend and heavy selling continues as 2.20 support is broken
2021-10-12 09:36 | Report Abuse
Really sad for those buying Comfort now another selling down to next support 1.10
2021-10-12 08:30 | Report Abuse
Worst case is pre pandemic price in 2019 between 70sen-90sen
2021-10-11 15:51 | Report Abuse
Careplus and Comfort going to join Ruberex below RM1 pre pandemic price in 2019
2021-10-11 15:43 | Report Abuse
Comfort pre pandemic price in 2019 is between 70-90 sen and today support 1.20 is going to be broken
2021-10-11 15:31 | Report Abuse
Glove stocks still very weak sentiment and still downtrend
2021-10-11 15:02 | Report Abuse
Many retailers trap buying high price above RM2+
2021-10-11 14:35 | Report Abuse
Top Glove still green but other glove stocks red sea
2021-10-11 12:04 | Report Abuse
Too high debts RM800+ millions and rights issue only able to raise RM140+ millions
2021-10-11 09:37 | Report Abuse
Very disappointing hopeless break new low 1.24 next support 1.20
2021-10-11 09:29 | Report Abuse
Careplus selling pressure very strong 1.10 support broken
2021-10-08 16:53 | Report Abuse
Supermax closing green rebound waiting next QR result end of November
2021-10-08 16:51 | Report Abuse
Hartalega falling down 10 sen today closing 5.89 waiting for upcoming QR result end of this month
2021-10-07 14:59 | Report Abuse
Supermax strong support 2.25 today buy queue 1 million shares
2021-10-07 14:43 | Report Abuse
KUALA LUMPUR (Oct 7): Glove makers have paused on share buy-backs despite stock prices nearing their lowest in a year.
In an Oct 7 note, TA Securities analyst Tan Kong Jin said that the average selling price (ASP) of nitrile gloves declined to US$40 to US$45 per 1,000 gloves in September compared with US$45 to US$50 per 1,000 gloves in August. Similarly, latex gloves' ASP dropped to US$30 to US$35 per 1,000 gloves in September versus US$35 to US$40 per 1,000 gloves in August.
"Going into October, we expect the nitrile and latex gloves' ASPs to be at US$35 to US$40 per 1,000 and US$25 to US$30 per 1,000 gloves respectively, representing about 8% to 12% month-on-month decline.
Tan, who has a "neutral" stance on the sector, maintains his "buy" calls on Hartalega and Kossan with lower target prices (TPs) of RM7.11 from RM10.30 previously, and RM2.71 from RM3.92.
He has maintained "sell" calls on Supermax with a lower TP of RM1.80 from RM2.71 previously and Top Glove with an unchanged TP of RM2.60.
2021-10-07 11:31 | Report Abuse
Those buying previous high price 3+/4+/5+/6+/7+ hope for dividends but share price everyday drops
2021-10-07 11:06 | Report Abuse
Still downtrend until next QR end November
2021-10-07 11:04 | Report Abuse
Almost back to pre-pandemic price 10sen
2021-10-06 22:35 | Report Abuse
@kbtsyl68... Those investors who sold earlier very good decision as they can buy much lower price now
2021-10-06 16:54 | Report Abuse
Supermax down but KLCI index shoot up 29 points
2021-10-06 16:52 | Report Abuse
Closing lowest 2.24 but KLCI index up 29 points
2021-10-05 14:49 | Report Abuse
Kossan bleeding again non stop selling everyday
2021-10-05 08:53 | Report Abuse
Another deep red sea KLCI index closer to breaking critical support level 1,500 points from yesterday closing 1,522 points
2021-10-05 08:46 | Report Abuse
Another deep red sea KLCI index closer to breaking critical support level 1,500 points from yesterday closing 1,522 points
2021-10-03 16:28 | Report Abuse
Tomorrow selling pressure continues for all glove stocks due to breakthrough news of Merck Covid-19 pills and strong rally of recovery stocks in US markets last Friday
2021-10-03 16:28 | Report Abuse
Tomorrow selling pressure continues for all glove stocks due to breakthrough news of Merck Covid-19 pills and strong rally of recovery stocks in US markets last Friday
2021-10-02 19:17 | Report Abuse
PETALING JAYA: Malaysia is negotiating to procure an experimental Covid-19 antiviral pill which can halve the chance of deaths or hospitalisation.
“As we transition to living with Covid-19, we will be adding new, innovative treatment options to our arsenal in addition to vaccines,” said health minister Khairy Jamaluddin on Twitter.
“I have already started negotiating for Malaysia to procure these effective drugs that have gone through clinical trials.”
Khairy attached a link to an article by news agency Reuters which said that the pill, which is being developed by the US-based Merck & Co and is known as molnupiravir, has been hailed as a “potential breakthrough” in the battle against the virus.
2021-10-02 19:16 | Report Abuse
PETALING JAYA: Malaysia is negotiating to procure an experimental Covid-19 antiviral pill which can halve the chance of deaths or hospitalisation.
“As we transition to living with Covid-19, we will be adding new, innovative treatment options to our arsenal in addition to vaccines,” said health minister Khairy Jamaluddin on Twitter.
“I have already started negotiating for Malaysia to procure these effective drugs that have gone through clinical trials.”
Khairy attached a link to an article by news agency Reuters which said that the pill, which is being developed by the US-based Merck & Co and is known as molnupiravir, has been hailed as a “potential breakthrough” in the battle against the virus.
2021-10-02 19:13 | Report Abuse
Really very volatile week for glove stocks next week as emergence of Merck Covid pills and other recovery stocks consumer,tech,oil and gas,aviation,gaming and financial rebound next week after yesterday US market up 500+ points
2021-10-02 19:12 | Report Abuse
Really very volatile week for glove stocks next week as emergence of Merck Covid pills and other recovery stocks consumer,tech,oil and gas,aviation,gaming and financial rebound next week after yesterday US market up 500+ points
Stock: [SUPERMX]: SUPERMAX CORPORATION BHD
2021-10-18 19:20 | Report Abuse
Waiting for next week Hartalega and Kossan QR announcement